These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 663871)

  • 1. Therapeutic action of Cavinton in hearing defects of neurological origin.
    Ordögh B; Sárossy D; Klimstein G
    Ther Hung; 1978; 26(1):16-9. PubMed ID: 663871
    [No Abstract]   [Full Text] [Related]  

  • 2. Action of Cavinton on hearing defects of different origin.
    Jasper A
    Ther Hung; 1978; 26(4):181-4. PubMed ID: 751275
    [No Abstract]   [Full Text] [Related]  

  • 3. Effectivity of Cavinton and Lucidril in the treatment of hearing defects of different origin.
    Jasper A
    Ther Hung; 1979; 27(1):29-31. PubMed ID: 386551
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cerebroxine and the treatment of hearing and equilibrium disorders. A double blind study].
    De Heyn G
    Brux Med; 1979 Mar; 59(3):157-62. PubMed ID: 373862
    [No Abstract]   [Full Text] [Related]  

  • 5. [About cavinton therapy of the patients with brain vascular diseases].
    Nikitina VV; Pravdina AN; Zapatrina OV
    Voen Med Zh; 2007 Feb; 328(2):43-5. PubMed ID: 17508611
    [No Abstract]   [Full Text] [Related]  

  • 6. [The effectiveness of Cavinton in retinal and choroid circulatory disturbances: I. Review of literature and material elaboration (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Zielińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):147-8. PubMed ID: 7392516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of cavinton in epilepsy].
    Dutov AA; Tolpyshev BA; Petrov AP; Gladun VN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(6):850-5. PubMed ID: 3751419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cavinton prevention of neurosensory hypoacousis in patients with different forms of tuberculosis].
    Maliavina US; Ovchinnikov IuM; Fasenko VP; Maliev BM; Kalinina MV; Dadasheva BB
    Vestn Otorinolaringol; 2003; (3):35-40. PubMed ID: 12847806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of cavinton on systemic and cerebral hemodynamics of patients with chronic cerebral circulatory insufficiency].
    Ishchenko MM; Shkrobot SI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1338-42. PubMed ID: 4072532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of circulatory encephalopathy with Cavinton].
    Lebedeva NV; Chukhrova VA; Solov'ev OU; Nepesov RR
    Klin Med (Mosk); 1997; 75(11):51-3. PubMed ID: 9490359
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical trials of using Cavinton in the form of intravenous infusion in the treatment of macular degeneration].
    Gerkowicz K; Toczołowski J; Jedrzejewski D; Jankowska I; Szponar B
    Klin Oczna; 1987 Mar; 89(3):95-6. PubMed ID: 3309450
    [No Abstract]   [Full Text] [Related]  

  • 12. [Strong delayed-action pervincamine in general medicine].
    Warembourg H; Ketelers JY
    Lille Med; 1975 Apr; 20(4):424-7. PubMed ID: 1152596
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effectiveness of cavinton in retinal and choroid circulatory disturbances: II. Results of own investigations and discussion (author's transl)].
    Swietliczkowa I; Zeydler-Grzedzielewska L; Baszczyńska-Ziellińska B; Braciak W
    Klin Oczna; 1980 Mar; 82(3):149-52. PubMed ID: 7392517
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of Cavinton drip infusion in ophthalmology. II. Effect of Cavinton drip infusion in eye diseases caused by vascular occlusion or stenosis.
    Imre G
    Ther Hung; 1986; 34(2):84-6. PubMed ID: 3449973
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of vascular retinal lesions with Cavinton (author's transl)].
    Oláh Z; Potocký M
    Cesk Oftalmol; 1981 Jan; 37(1):19-23. PubMed ID: 7471250
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pentoxifylline in changes of the statoacoustic apparatus during vascular diseases. Its action on erythrocyte flexibility].
    Pallestrini E; Garaventa G; Cagetti P; Benedetti G; Valle MT; Accomando E; Castiglia G
    Clin Ter; 1986 Aug; 118(4):239-46. PubMed ID: 3489580
    [No Abstract]   [Full Text] [Related]  

  • 17. Cavinton in the treatment of acute stroke.
    Kovács L
    Ther Hung; 1985; 33(1):50-7. PubMed ID: 3841999
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of psychophysiologic characteristics of patients in the efficacy of treatment with cavinton].
    Lil'in ET; Mar'in MI; Trubnikov VI; Vavilova TA
    Sov Med; 1983; (10):111-3. PubMed ID: 6658534
    [No Abstract]   [Full Text] [Related]  

  • 19. Observations with Cavinton (RGH-4405).
    Alberth B; Somogyi E
    Ther Hung; 1979; 27(1):17-27. PubMed ID: 494138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effectiveness of using cavinton in patients of different ages with chronic forms of cerebrovascular diseases (clinico-rheographic research)].
    Burtsev EM; Shprakh VV; Savkov VS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(1):39-44. PubMed ID: 3364094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.